Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: Preliminary clinical results
Open Access
- 1 December 1998
- journal article
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 28 (6), 964-975
- https://doi.org/10.1016/s0741-5214(98)70022-9
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- VEGF Improves Myocardial Blood Flow but Produces EDRF-Mediated Hypotension in Porcine HeartsJournal of Surgical Research, 1996
- Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression.Journal of Clinical Investigation, 1996
- Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs.Circulation, 1994
- Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model.Journal of Clinical Investigation, 1994
- Gene Therapy by Intramuscular Injection of Plasmid DNA: Studies on Firefly Luciferase Gene Expression in MiceHuman Gene Therapy, 1993
- Widespread long-term gene transfer to mouse skeletal muscles and heart.Journal of Clinical Investigation, 1992
- Direct Gene Transfer into Mouse Muscle in VivoScience, 1990
- Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliteransThe Lancet, 1990
- Buerger's disease in the modern eraThe American Journal of Surgery, 1987
- THROMBO-ANGIITIS OBLITERANSThe Lancet Healthy Longevity, 1908